The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica

(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen tre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jacob Venborg, Anne-Marie Wegeberg, Salome Kristensen, Birgitte Brock, Christina Brock, Mogens Pfeiffer-Jensen
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
PMR
R
Acceso en línea:https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:60d7f9aa2a1d4fc7927d438ff4fb340e
record_format dspace
spelling oai:doaj.org-article:60d7f9aa2a1d4fc7927d438ff4fb340e2021-11-25T18:39:52ZThe Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica10.3390/ph141111661424-8247https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1166https://doaj.org/toc/1424-8247(1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen treatment-naïve PMR patients completed the study. Patients underwent a 5-day protocol, receiving 2 min of t-VNS stimulation bilaterally on the neck, three times daily. Cardiac vagal tone (CVT) measured on a linear vagal scale (LVS), blood pressure, heart rate, patient-reported outcome, and biochemical changes were assessed. (3) t-VNS induced a 22% increase in CVT at 20 min after initial stimulations compared with baseline (3.4 ± 2.2 LVS vs. 4.1 ± 2.9 LVS, <i>p</i> = 0.02) and was accompanied by a 4 BPM reduction in heart rate (73 ± 11 BPM vs. 69 ± 9, <i>p</i> < 0.01). No long-term effects were observed. Furthermore, t-VNS induced a 14% reduction in the VAS score for the hips at day 5 compared with the baseline (5.1 ± 2.8 vs. 4.4 ± 2.8, <i>p</i> = 0.04). No changes in CRP or proinflammatory analytes were observed. (4) t-VNS modulates the autonomic nervous system in patients with PMR, but further investigation of t-VNS in PMR patients is warranted.Jacob VenborgAnne-Marie WegebergSalome KristensenBirgitte BrockChristina BrockMogens Pfeiffer-JensenMDPI AGarticlepolymyalgia rheumaticavagus nerve stimulationinflammatory responsePMRt-vnsMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1166, p 1166 (2021)
institution DOAJ
collection DOAJ
language EN
topic polymyalgia rheumatica
vagus nerve stimulation
inflammatory response
PMR
t-vns
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle polymyalgia rheumatica
vagus nerve stimulation
inflammatory response
PMR
t-vns
Medicine
R
Pharmacy and materia medica
RS1-441
Jacob Venborg
Anne-Marie Wegeberg
Salome Kristensen
Birgitte Brock
Christina Brock
Mogens Pfeiffer-Jensen
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
description (1) Polymyalgia rheumatica (PMR) is an inflammatory disease characterised by pain, morning stiffness, and reduced quality of life. Recently, vagus nerve stimulation (VNS) was shown to have anti-inflammatory effects. We aimed to examine the effect of transcutaneous VNS (t-VNS) on PMR. (2) Fifteen treatment-naïve PMR patients completed the study. Patients underwent a 5-day protocol, receiving 2 min of t-VNS stimulation bilaterally on the neck, three times daily. Cardiac vagal tone (CVT) measured on a linear vagal scale (LVS), blood pressure, heart rate, patient-reported outcome, and biochemical changes were assessed. (3) t-VNS induced a 22% increase in CVT at 20 min after initial stimulations compared with baseline (3.4 ± 2.2 LVS vs. 4.1 ± 2.9 LVS, <i>p</i> = 0.02) and was accompanied by a 4 BPM reduction in heart rate (73 ± 11 BPM vs. 69 ± 9, <i>p</i> < 0.01). No long-term effects were observed. Furthermore, t-VNS induced a 14% reduction in the VAS score for the hips at day 5 compared with the baseline (5.1 ± 2.8 vs. 4.4 ± 2.8, <i>p</i> = 0.04). No changes in CRP or proinflammatory analytes were observed. (4) t-VNS modulates the autonomic nervous system in patients with PMR, but further investigation of t-VNS in PMR patients is warranted.
format article
author Jacob Venborg
Anne-Marie Wegeberg
Salome Kristensen
Birgitte Brock
Christina Brock
Mogens Pfeiffer-Jensen
author_facet Jacob Venborg
Anne-Marie Wegeberg
Salome Kristensen
Birgitte Brock
Christina Brock
Mogens Pfeiffer-Jensen
author_sort Jacob Venborg
title The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
title_short The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
title_full The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
title_fullStr The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
title_full_unstemmed The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
title_sort effect of transcutaneous vagus nerve stimulation in patients with polymyalgia rheumatica
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/60d7f9aa2a1d4fc7927d438ff4fb340e
work_keys_str_mv AT jacobvenborg theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT annemariewegeberg theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT salomekristensen theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT birgittebrock theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT christinabrock theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT mogenspfeifferjensen theeffectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT jacobvenborg effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT annemariewegeberg effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT salomekristensen effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT birgittebrock effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT christinabrock effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
AT mogenspfeifferjensen effectoftranscutaneousvagusnervestimulationinpatientswithpolymyalgiarheumatica
_version_ 1718410837559869440